Filters

See more specimen types...

Other countries

Results: 1 to 20 of 44 (representing 17 labs)

Tests names and labsConditionsGenes and analytesMethods

CentoColon extended panel

Centogene AG - the Rare Disease Company
Germany
1917
  • C Sequence analysis of the entire coding region

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

CentoBreast (hereditary breast cancer) panel

Centogene AG - the Rare Disease Company
Germany
1013
  • C Sequence analysis of the entire coding region

Li-Fraumeni syndrome type 2

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Vistaseq Hereditary Cancer Panel Without BRCA

Molecular Diagnostic Laboratory LabCorp
United States
1725
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

VistaSeq Hereditary Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
1827
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Tier 1: Hereditary Lymphoma and Immunodeficiency Panel

Genetic Services Laboratory University of Chicago
United States
611
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Sequencing And Deletion/Duplication Panel

PreventionGenetics
United States
2117
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Li Fraumeni Syndrome Type 2 , Sequencing CHEK2 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Hereditary Colorectal/Gastrointestinal Cancer Panel

Baylor Miraca Genetics Laboratories
United States
5922
  • E Sequence analysis of select exons

Comprehensive Hereditary Cancer Panel

Baylor Miraca Genetics Laboratories
United States
13561
  • E Sequence analysis of select exons

Hereditary Prostate Cancer Panel

Baylor Miraca Genetics Laboratories
United States
245
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Hereditary Cancer Syndromes - panels

Medizinisch Genetisches Zentrum München MGZ München
Germany
6100
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Prostate Cancer Focus Panel

Fulgent Genetics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Ovarian Cancer Focus Panel

Fulgent Genetics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Endometrial Cancer Focus Panel

Fulgent Genetics
United States
5810
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Colorectal Cancer Focus Panel

Fulgent Genetics
United States
5816
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast Cancer Focus Panel

Fulgent Genetics
United States
5814
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Colorectal and Gastrointestinal Cancer Panel

Division of Genomic Diagnostics The Children's Hospital of Philadelphia
United States
3523
  • S Mutation scanning of the entire coding region

Focus Cancer Panel - 40 Genes

Fulgent Genetics
United States
5640
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 44

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center